Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump ... Montarce said the company can absorb the impact of tariffs within the 2025 guidance and ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Johnson & Johnson factored roughly $400 million into its 2025 guidance to account for the impact ... the Trump administration could unleash an even bigger threat than tariffs to AbbVie, Lilly ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...